The Week In Cannabis: A Mixed Bag Leads Marijuana Stocks To Underperform – Benzinga

This week brought a mixed bag of news for the cannabis industry.

Aphria Inc (NYSE: APHA) announced it will transfer its stock from the New York Stock Exchange to the Nasdaq exchange after the market close June 5, and a long list of earnings reports, some better than others.

Cresco Labs Inc. (CSE: CL) (OTC: CRLBF) had a great week with numerous store-opening announcements. The company also reported first-quarter revenue of $66.4 million, up 60% from the previous quarter. “In Q1 we built, staffed, integrated, and refined our operations in the largest and most important cannabis markets in the U.S.,” said the company’s co-founder and CEO Charles Bachtell.

TerrAscend Corp. (CSE: TER) (OTC: TRSSF) reported net sales of CA$34.8 million (US$25.2 million) for the first quarter of 2020, up 34% quarter-over-quarter and 139% year-over-year. The Toronto-based company reached a positive adjusted EBITDA of CA$4.9 million versus a loss of CA$5.5 million in the corresponding quarter last year.

Amid restructuring efforts, Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) reported a fourth-quarter net loss of CA$1.3 billion ($946.4 million), up from the loss of CA$347.5 million it posted for the same quarter a year ago. On the other hand, net revenue of CA$399 million was up 76% year-over-year, but down 13% quarter-over-quarter. See the full results here.

Following the report, Eric Choe, founder of StockDweebs, said Canopy Growth is well-positioned to rally on the production, distribution and sale of its cannabis products despite the recent downfall: “It relies primarily on retail traffic and the sale of medicinal and recreational cannabis products – this could boost overall sales and top-line figures once stores start opening post-COVID.”

Cantor Fitzgerald’s Pablo Zuanic seemed to disagree, noting the company has considerable downside risk following the fourth-quarter report.

See more financial results from Vibe Bioscience Ltd. (CSE: VIBE) (OTC: VBSCF), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), Slang Worldwide (CNSX: SLNG), Evogene Ltd. (NASDAQ: EVGN), and more, at our Cannabis Earnings Center.

Don’t miss this opportunity to connect with THE cannabis movers and shakers from across the globe during Benzinga’s first Virtual Cannabis Capital Conference on June 1.

For their part, ETFs closed the week on the red. Over the five trading days of the week:

  • ETFMG Alternative Harvest ETF (NYSE: MJ) lost 2%.
  • AdvisorShares Pure Cannabis ETF (NYSE: YOLO) slipped 0.37%.
  • Cannabis ETF (NYSE: THCX) dropped 3.85%.
  • Amplify Seymour Cannabis ETF (NYSE: CNBS) shed 2.83% of its value.
  • SPDR S&P 500 ETF Trust (NYSE: SPY) closed the period up 2.95%.

Debra Borchardt, CEO of Green Market Report called the earnings results “staggering,” adding “It seems like it will be a long time before these companies can recover from past management decisions and give investors a company that they can believe in.”

In other news, real estate investment trust Innovative Industrials Properties (NYSE: IIPR) reported the upsize and pricing of an underwritten public offering of its common shares at an estimated cost of $100 million. The offering consists of 1,348,389 common shares.

Banking and payment technology company Hypur partnered with business software provider Odoo to streamline the cannabis purchasing process. Together they will provide modern, digital payments, and bolster point-of-sale operations. The partnership will also enable customers utilize Hypur’s new nationwide “safe checkout” feature, which was recently rolled out with Caliva, as well as online cannabis marketplace, Dutchie.

Psychedelics company Red Light Holland Corp. started trading on the Canadian Securities Exchange under the ticker symbol “TRIP,” and appointed Bruce Linton, the co-founder and former CEO of Canopy Growth, as chairman of its advisory board.

Advanced Flower Capital Management LLC confirmed its associate has provided Nature’s Medicines with $42 million in financing.

Louisiana is moving forward with a piece of legislation that would make medical marijuana move easily available in the state by authorizing recommendations from any state-licensed physician, while updating the list of qualifiable medical conditions.

House Bill 819 passed Senate vote on Wednesday by 28 to 6.

Find our cannabis, hemp and psychedelics news in Spanish on El Planteo.

More News From The Week

True Terpenes, a producer of GMP/ISO/FSSC-certified terpenes, formed a scientific advisory board (SAB) to advance research in the cannabis industry. The SAB will be focused on studying the entourage effect, where the benefits of medical cannabis can be enhanced when combined with terpenes. Board members include Dr. Ethan Russo, a cannabis and pharmaceutical scientist who specializes in the entourage effect. Dr. Russo previously worked with GW Pharmaceuticals on progressing Epidiolex and Sativex through clinical trials, becoming the first cannabis-based drug to be approved by the Food & Drug Administration.

„There is a growing body of anecdotal evidence that supports the existence of the entourage effect. The profound potential for cannabis medicine to positively impact human health compels the cannabis industry to establish scientific proof of the synergistic interaction between terpenes and cannabinoids. True Terpenes has unmatched access to the global terpenes supply chain and a proprietary library of terpene profiles that our company is contributing to these efforts,” said CEO Chris Campagna.

New Wave Holdings Corp. (CSE: SPOR) (OTC: TRMND)  announced its plans to sponsor TheraPsil, a Victoria, British Columbia-based non-profit coalition seeking legal access to psilocybin for Canadians in palliative care. The coalition is focused on providing legal, safe access to psychedelic therapies as well as education. In collaboration with domestic and global partners, the organization plans to help support the development of effective protocols in collaboration with health professionals.

„We are looking forward to working with TheraPsil to help bring psychedelic therapy to patients in palliative care. It is through education, training, research and the championing of those patients who could benefit from access to these therapies that we will see this initiative move forward and see so many people be helped,” said Trumbull Fisher, President of New Wave.    

Medical Marijuana, Inc. (OTC: MJNA) subsidiary Kannaway welcomed Earl Monroe, former NBA player for the Baltimore Bullets and the New York Knicks, to its Sports Team to help spread awareness on the benefits of CBD for athletes. Monroe played 13 seasons in the NBA. He was inducted into the Naismith Memorial Basketball Hall of Fame in 1990. 

„Earl uses our Premium Full Spectrum CBD and topical salve products to help manage the aches that are a result of many years of championing a professional sport,” said Kannaway® CEO Blake Schroeder. „We could not be more proud that our products have made a positive difference for him,”

A class-action lawsuit claiming Colorado-based Elixinol, LLC’s CBD products were illegal to sell under federal regulations was dismissed. The company creates, manufactures and sells various CBD products, including capsules, tinctures and dog treats. In McCarthy v Elixinol, LLC, lawyers argued that under the 2018 Farm Bill the hemp-derived CBD company had the right to transport and ship hemp. In addition, the FDA’s current regulations do not prohibit any company from selling hemp-based products. The suit was filed in the United States District Court for the Northern District of California in December 2019.

“Elixinol isn’t the only hemp and CBD company facing these unfounded class action lawsuits,” says Jonathan Miller, chair of Frost Brown Todd’s hemp industry team and general counsel of the U.S. Hemp Roundtable. “These attorneys previously earned a similar dismissal in Fausett, et al. v. Koi CBD, LLC and are working other pending cases claiming product impurities and failed drug tests. The 2018 Farm Bill made hemp legal and companies running legitimate businesses that are building this new industry should be welcomed and embraced.”

Top Stories Of The Week

Check out the top stories on Benzinga Cannabis this week:

Check out these and many other cannabis stories on Benzinga.com/cannabis

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

The Week In Cannabis: A Mixed Bag Leads Marijuana Stocks To Underperform – Yahoo Finance

This week brought a mixed bag of news for the cannabis industry.

APHA) announced it will transfer its stock from the New York Stock Exchange to the Nasdaq exchange after the market close June 5, and a long list of earnings reports, some better than others.

CRLBF) had a great week with numerous store-opening announcements. The company also reported first-quarter revenue of $66.4 million, up 60% from the previous quarter. “In Q1 we built, staffed, integrated, and refined our operations in the largest and most important cannabis markets in the U.S.,” said the company’s co-founder and CEO Charles Bachtell.

TRSSF) reported net sales of CA$34.8 million (US$25.2 million) for the first quarter of 2020, up 34% quarter-over-quarter and 139% year-over-year. The Toronto-based company reached a positive adjusted EBITDA of CA$4.9 million versus a loss of CA$5.5 million in the corresponding quarter last year.

here.” data-reactid=”23″>Amid restructuring efforts, Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) reported a fourth-quarter net loss of CA$1.3 billion ($946.4 million), up from the loss of CA$347.5 million it posted for the same quarter a year ago. On the other hand, net revenue of CA$399 million was up 76% year-over-year, but down 13% quarter-over-quarter. See the full results here.

Following the report, Eric Choe, founder of StockDweebs, said Canopy Growth is well-positioned to rally on the production, distribution and sale of its cannabis products despite the recent downfall: “It relies primarily on retail traffic and the sale of medicinal and recreational cannabis products – this could boost overall sales and top-line figures once stores start opening post-COVID.”

Cantor Fitzgerald’s Pablo Zuanic seemed to disagree, noting the company has considerable downside risk following the fourth-quarter report.

Cannabis Earnings Center.” data-reactid=”26″>See more financial results from Vibe Bioscience Ltd. (CSE: VIBE) (OTC: VBSCF), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), Slang Worldwide (CNSX: SLNG), Evogene Ltd. (NASDAQ: EVGN), and more, at our Cannabis Earnings Center.

Benzinga’s first Virtual Cannabis Capital Conference on June 1.” data-reactid=”27″>Don’t miss this opportunity to connect with THE cannabis movers and shakers from across the globe during Benzinga’s first Virtual Cannabis Capital Conference on June 1.

For their part, ETFs closed the week on the red. Over the five trading days of the week:

  • ETFMG Alternative Harvest ETF (NYSE: MJ) lost 2%.
  • AdvisorShares Pure Cannabis ETF (NYSE: YOLO) slipped 0.37%.
  • Cannabis ETF (NYSE: THCX) dropped 3.85%.
  • Amplify Seymour Cannabis ETF (NYSE: CNBS) shed 2.83% of its value.
  • SPDR S&P 500 ETF Trust (NYSE: SPY) closed the period up 2.95%.

Debra Borchardt, CEO of Green Market Report called the earnings results “staggering,” adding “It seems like it will be a long time before these companies can recover from past management decisions and give investors a company that they can believe in.”

IIPR) reported the upsize and pricing of an underwritten public offering of its common shares at an estimated cost of $100 million. The offering consists of 1,348,389 common shares.

House Bill 819 passed Senate vote on Wednesday by 28 to 6.

El Planteo.” data-reactid=”42″>Find our cannabis, hemp and psychedelics news in Spanish on El Planteo.

More News From The Week

„There is a growing body of anecdotal evidence that supports the existence of the entourage effect. The profound potential for cannabis medicine to positively impact human health compels the cannabis industry to establish scientific proof of the synergistic interaction between terpenes and cannabinoids. True Terpenes has unmatched access to the global terpenes supply chain and a proprietary library of terpene profiles that our company is contributing to these efforts,” said CEO Chris Campagna.

TRMND)  announced its plans to sponsor TheraPsil, a Victoria, British Columbia-based non-profit coalition seeking legal access to psilocybin for Canadians in palliative care. The coalition is focused on providing legal, safe access to psychedelic therapies as well as education. In collaboration with domestic and global partners, the organization plans to help support the development of effective protocols in collaboration with health professionals.

„We are looking forward to working with TheraPsil to help bring psychedelic therapy to patients in palliative care. It is through education, training, research and the championing of those patients who could benefit from access to these therapies that we will see this initiative move forward and see so many people be helped,” said Trumbull Fisher, President of New Wave.    

MJNA) subsidiary Kannaway welcomed Earl Monroe, former NBA player for the Baltimore Bullets and the New York Knicks, to its Sports Team to help spread awareness on the benefits of CBD for athletes. Monroe played 13 seasons in the NBA. He was inducted into the Naismith Memorial Basketball Hall of Fame in 1990. 

„Earl uses our Premium Full Spectrum CBD and topical salve products to help manage the aches that are a result of many years of championing a professional sport,” said Kannaway® CEO Blake Schroeder. „We could not be more proud that our products have made a positive difference for him,”

Top Stories Of The Week

Check out the top stories on Benzinga Cannabis this week:

  • A Medicinal Cannabis Company That’s Conducting Clinical Research On Autism, Insomnia, And More
  • Poison Pills: A Common Component In Lawmaking, M&A And Now Cannabis
  • A Snapshot of America’s Medical Marijuana Marketplaces: Michigan
  • Cannabis Strain Names Are Meaningless: What Is The Industry Doing About It?
  • Virtual Benzinga Cannabis Capital Conference Offers Sneak Peek At Pot Industry’s Coronavirus Recovery
  • MindMed To Include MDMA to Research Portfolio
  • Benzinga Cannabis Capital Conference Presents: Vivien Azer, Star Marijuana Analyst
  • Benzinga Cannabis Capital Conference Presents: Isiah Thomas, NBA Legend And CBD Investor
  • Benzinga Cannabis Capital Conference Presents: From Bud to Bloom – Grow Your Business The Right Way
  • What Isiah Thomas, John Salley And Al Harrington Have In Common (Hint: It’s Not Basketball)

NACB Recommends Regional Approach to Cannabis Legalization, Tilray Plans to Close High Park Gardens Facility in Ontario: Week in Review – Cannabis Dispensary

The continued legalization of cannabis across the U.S. is expected to drive a surge in advertising spending in the coming years. Case in point, market and consumer data provider Statista projects that ad spending by cannabis companies in North America will grow from $661 million in 2018 to $3.89 billion over a 10-year period.

While growth expectations are dramatic and impressive, cannabis brands are faced with significant challenges in their marketing efforts. Many channels, including Google and Facebook, do not accept cannabis ads, and the ones that do come with many complex restrictions.

In these relatively early days of cannabis legality, out-of-home (OOH) advertising has emerged as the advertising channel of choice for cannabis brands. In addition to being one of the few remaining mediums capable of reaching a mass audience, OOH offers fewer restrictions than other channels, is cost effective for early-stage brands, and is proven to influence consumer attitudes and behaviors like web or foot-traffic to dispensaries.

But OOH planning for cannabis brands also requires awareness and real-time tracking of the ever-changing labyrinth of regulations and laws dictating where advertising can be placed and what can be shown in an ad. These laws differ not only by state, but by county and individual municipality. And with more than 1.5 million screens and displays, the U.S. OOH market is complex even for a traditional brand, let alone one that also has to navigate numerous restrictions on content and placement.

However, with investments and advancements in data aggregation technologies and the emergence of new campaign planning tools and platforms, it is possible for cannabis brands to quickly and safely leverage OOH to grow their businesses.

By adhering to these five key considerations, cannabis brands can leverage OOH safely, legally and effectively.

1. Look Before Leaping

Cannabis legalization occurs on a state-by-state basis. No two states have exactly the same sets of laws and guidelines. As a once-banned activity becomes legal in a given state, there is a rush to market with a flood of advertising activity. Take the time to truly understand the regulatory nature, and any sensitivities, before launching headlong into your advertising efforts.

2. Be Mindful of the Space You Are In

Yes, new data-driven planning tools and platforms enable the quick and easy identification of usable and compliant locations. However, even after ensuring that the selected inventory complies with all the necessary regulations, consider whether the message is truly appropriate for the community and surrounding areas where it will be seen. Just because you can promote your product on a particular OOH screen doesn’t necessarily mean you should. Criticism and community blowback come into play, even when you’re operating within your legal rights.   

3. Create a Sense of Shared Accountability

Sometimes, despite best efforts, issues arise. Have a plan in place ahead of time to manage complaints, incoming press inquiries or any other speed bumps. Establish a culture of shared accountability among all partners so that issues can be tackled quickly and effectively.

4. Leverage Partners

Today, any company can easily buy a billboard by calling up the media owner, but by working with an OOH specialist agency, cannabis brands can access a wider range of opportunities and capitalize on the experience and volume they manage to secure the very best locations and audiences for the best price. Specialist partners can also make it easier to navigate the complexities of OOH campaigns with turn-key and end-to-end solutions covering planning, execution, price negotiation, payment and reporting.

5. Ensure Every Channel Has a Seat at Your Table

Finally, too often, OOH is added on at the end of the wider planning process, as a secondary consideration or something “nice to have.” This is true both for cannabis and mainstream brands. To maximize the role of all channels in a marketing plan, bring everyone to the table from day one as the strategy is being developed. Marrying the vision from the start ensures ideas come to life across every brand communication and creates greater chance of success in delivering on business objectives. 

Shabnam Irilian is managing director for Talon Outdoor, an out-of-home agency delivering creative, technology-led and integrated OOH communications.

Sale Alert: 10% off CBD products and free shipping – Golf.com


Warning: sprintf(): Too few arguments in /var/www/vaporizers.pl/wp-content/themes/blogito/inc/template-tags.php on line 319
Golf CBD products

On the Green makes CBD products for golfers.

Courtesy

Over the past few weeks we’ve featured a number of CBD products from On The Green, a CBD company that specializes in making products specifically designed for golfers. CBD is one of the key ingredients in cannabis, and it can be extracted and infused into a a variety of different products they may be able to help on the course.

And this weekend, On the Green is running a special on one in particular: CBD Arnica + Tumeric Relief Cream. The product includes 300 mg of cannabidiol and comes in a 1.7 oz package. It’s designed to be applied directly to the skin to help relieve muscle pain. Ordinarily $49.99, the price has been dropped to $42.99 this weekend, and you can get an extra 10% off using the code GOLF10

(300MG) ARNICA + TURMERIC RELIEF CREAM

$42.99 (additional 10% off using code GOLF10)

Our Arnica + Turmeric Relief Cream is enhanced with 300mg of Broad Spectrum CBD oil and contains potent anti-inflammatory properties to aid in pre- and post-round pain relief.

Buy Now

And if you want to try another 10%-off product and get free shipping, which accompanies any purchase of $50 or more, we suggest a bottle of CBD hand sanitizer. It’s small enough to keep in your bag,

(200MG) HAND SANITIZER GEL | 100MG CBD + 100MG CBG

$25.49 (additional 10% off using code GOLF10)

On The Green CBD Hand Sanitizer is a combination of 70% ethyl alcohol infused with 100MG of CBD and 100MG of CBG. Use code GOLF10 at checkout to receive 10% off your order.

Buy Now

The product(s) featured in this article has been independently selected by GOLF.com’s editorial team. If you make a purchase using the links included, we may earn a small commission.

Latest In Instruction

generic profile image

THC breathalyzer program could help police detect marijuana impairment – NonDoc

THC breathalyzerA THC breathalyzer like this made by Hound Labs in California would be used in a pilot program in Oklahoma. (Hound Labs)

Oklahoma law enforcement officers patrolling the state’s roads and highways may soon have a new tool for testing drivers who they believe may be under the influence of marijuana.

Signed by Gov. Kevin Stitt on May 2, HB 4161 directs the Oklahoma Department of Public Safety to spend $300,000 to create a pilot program to explore the use of breathalyzers to detect tetrahydrocannabinol (THC), which is the primary psychoactive component of marijuana.

Rep. Scott Fetgatter (R-Okmulgee) is among the most engaged state legislators on the topic of Oklahoma’s medical marijuana industry. He said he had first raised the idea of a breathalyzer program at “a meeting in February with representatives from city police, county sheriffs and the Department of Public Safety.”

“We took them through the science behind the breathalyzer, and I took a vote among those in the room if they were interested, and it was unanimous,” he said. “They were all in favor of the idea of a pilot program.”

The development of a device to detect THC from a user’s breath has puzzled scientists for years. Having a dependable breathalyzer would solve a sticky problem for officers in the field, who lack the ability to accurately and quickly test impaired drivers rather than using drug recognition experts and blood tests.

How the technology works

A THC breathalyzer made by Hound Labs in California. (Hound Labs)

One company the state has been talking to is the California-based Hound Labs, which makes $3,000 THC breathalyzer devices.

Using a Hound Labs THC breathalyzer is similar to using an alcohol breathalyzer. A disposable cartridge with a plastic tube is inserted into the device, which is about the size of a large smartphone. The user then blows into the tube for 30 seconds. Quickly, the device determines the level of THC in the user’s system.

According to the the company’s website, the device can detect THC at levels of one trillionth of a gram per liter of breath. That means if someone smoked marijuana or consumed edibles three hours before, it would be detected in their breath by the device.

How high is too high?

But the quantity of THC needed to cause impairment has not been clearly established. While .08 is commonly used as a blood alcohol level standard in many states, no such baseline exists for THC.

In Colorado, anyone operating a motor vehicle with more than 5 nano-grams per milliliter of blood is considered impaired. A nano-gram is one billionth of a gram.

Currently, Oklahoma has a zero tolerance policy when it comes to the presence of THC in blood. Any amount is considered illegal while operating a motor vehicle, even if the user has a medical marijuana license.

“If you take a blood test and you test hot for marijuana, it’s an automatic DUI,” Fetgatter said. “That’s terrible, because you may not have used it in a week. I’m trying to solve a problem so we don’t convict people of DUI simply because of the way marijuana metabolizes in their blood.”

Establishing a baseline for impairment is one of the goals of the pilot program, Fetgatter said.

“We haven’t gotten that deep into the machine calibrations and how that will be done, which is another reason why we need to do the pilot program,” Fetgatter said. “It is subjective. Someone who uses marijuana regularly might not be affected in the same way as someone who uses it for the first time. Just like for me — I don’t drink, so if I go out and have two glasses of wine, it might affect me differently than someone who regularly drinks.”

‘It would be a great tool to have’

Oklahoma Department of Public Safety spokeswoman Sarah Stewart told The Oklahoman it could take up to a year for the program to get off the ground. Stewart said the department hopes to observe other states as they make forays into using breathalyzers in order to help determine rules for Oklahoma’s program.

When it does start, participation in the pilot program will be voluntary and results won’t be admissible in court. People pulled over on suspicion of driving under the influence will have the option of using the breathalyzer or undergoing blood tests. As an incentive to participate, a driver who opts for the breathalyzer might be released to a relative or friend rather than be taken to jail. Fetgatter stressed none of those details have been finalized, however.

“None of the information collected during the pilot would be admissible in court or held against you, in the event it is used in the field,” Fetgatter said. “If someone fails a field sobriety test and is under suspicion of using drugs, that impaired person might be given the option of using the breathalyzer and be released to someone who is able to drive them home if they were willing to participate in the pilot, but a lot of that hasn’t been worked out.”

Options needed 

Blood tests can take several days to process. Beyond that, they don’t always reflect the driver’s level of impairment at the time the sample was collected, because THC can be detected in a person’s system weeks after use.

Midwest City Police Chief Brandon Clabes said he is in favor of adding tools for law enforcement officers. Currently, Midwest City, like all police departments, relies on blood tests and officers trained as drug recognition experts to determine if a driver is impaired by something other than alcohol.

“The blood tests aren’t really cost prohibitive, but they do have to best sent to the OSBI lab, which can take some time,” he said. “We also have officers who are DREs, and they go to school for that. It’s a two-week program that is very intense. But it is also labor intensive.”

Clabes said he hasn’t seen an increase in impaired drivers in Midwest City since the state’s medical marijuana program started, in 2018, but he said he knew when it began that the issue of driver impairment might be troublesome.

“When they first passed it, I knew we would probably need some technological advances in the way we handle these situations in the field,” he said. “Now it looks like that has come to fruition. Of course, it still has a ways to go with the process, but it sounds like it would be a great tool to have.”

HB 3228 remains dead

On May 21, Stitt vetoed HB 3228, a bill that would have made adjustments to various regulations of the state’s medical marijuana dispensaries.

The bill was presented to legislators as putting in place measures requested by the Oklahoma Medical Marijuana Authority. It passed the House 90-6 and the Senate 38-5.

In his veto message, Stitt said the bill “makes substantial policy changes to the medical marijuana program that were not fully scrutinized through normal legislative procedures.”

Stitt’s action was criticized by Fetgatter and others, but lawmakers ultimately did not try to override the veto before the Legislature’s official sine die adjournment May 29. (Though lawmakers left the Capitol on May 22.)

Senate President Pro Tempore Greg Treat (R-OKC) told NonDoc last week that the Senate did not have the votes for a veto override on HB 3228. He also said questions had been raised about whether the director of the Oklahoma Medical Marijuana Authority actually wanted all measures in the bill to be put in place.

Best CBD Oil for Sleep: Our Top Picks – Cleveland Scene

click to enlarge try_the_cbd_photo.jpg

Everyday life, stress from work, worries about finances and other problems we are facing constantly are often triggering pain, anxiety, or lead to various health conditions. Naturally, everyone is looking for a relief mainly through medicine, but even more through incorporating healthy habits into their daily routine. It’s understandable that people prefer to find a way out of pain using natural products and treatments than taking different medications. One of the most popular methods of relieving pain nowadays is the CBD oil. More and more people have started using CBD oil for pain, and many brands selling this product appeared on the market.

What is CBD Oil?

This popular product is widely used, however, there are certain things worth mentioning if you consider trying CBD oil. Firstly, CBD oil is a product made from a substance called cannabidiol or shortly CBD, which is extracted from the hemp plant. Hemp consists of many cannabinoids – different chemical compounds that are known to have therapeutic properties. CBD is such a cannabinoid and is considered to have a great effect in treating many health conditions. For that reason, people started growing hemp and extracting this cannabinoid in order to produce the CBD oil and offer it to anyone in need.

Very often people are under the wrong impression that CBD is the same as marijuana, hence the myth that CBD can get you high. The truth is that there is another cannabinoid called THC or tetrahydrocannabinol found in the hemp plant and this is the substance that causes the psychoactive effects. In the process of production of CBD oil, this substance is not included or appears at a very low level which is not harmful. Therefore, consuming CBD oil does not cause an intoxicating effect.

Top Picks: Best CBD Oil for Pain

Today there are many brands offering oil tinctures and other CBD products with different qualities. If you are curious to try it, or you are in the process of selection, we have done our research to help you choose the finest CBD oil to treat your condition. Here are our top picks of the best CBD oil for pain available for sale.

1. Try The CBD

Highlights

  • Made from organic Colorado-grown hemp
  • Full-spectrum and THC-free CBD Oil
  • Potency 200mg to 5000mg CBD
  • Lab-tested for purity
  • Affordable prices and special discounts

Try The CBD is the brand that is on the top of our list due to the top-quality product they sell at a very affordable price. Based in Denver, Colorado, this company uses only organic non-GMO hemp of the highest quality and extracts the CBD using the safe CO2 extraction method. At their store, you can find pure CBD oil for sale as there are no artificial ingredients added. They offer two types – full-spectrum CBD oil with less than 0.3% of THC in its compound and THC-free CBD oil that contains no THC.

What’s great about them is that all their products are tested by an independent lab and the lab results are published on their official website right next to each product. In that way, you can see the ingredient list and reassure that the products are pesticides-free and contain no heavy metal. Furthermore, they offer a palette of CBD oils with different potencies. The strongest oil contains 5000mg and the lowest has 200mg of CBD. With Try The CBD you get a top-notch product that is cost-effective.

Tip: If you subscribe to their newsletter you can take advantage of the numerous discounts they offer and there is even an all-time discount for a certain group of customers, such as veterans, students, low-income families, and people with disabilities.

2. HealthworxCBD

Highlights

  • Full-spectrum, THC-Free, and Terpene-enhanced CBD Oil
  • Oils specifically formulated to help relax, for sleep, energy, and focus.
  • Made from organic hemp
  • Organic MCT coconut oil as carrying oil
  • Lab-tested

If you are looking for a top-grade CBD oil for sale, HealthworxCBD is the place to find it. They have created a specific formula for treating a specific condition. For example, you can get CBD oil for sleep, energy, focus or to help you relax. Also, you can choose the strength as there are oils with 200mg, 500mg, 1,500mg, and up to 5000mg of CBD.

HealthworxCBD also uses organic hemp grown in the Colorado fields and adds only natural ingredients. All products available in their shop are tested by an independent lab because they never compromise their quality by using inferior raw materials and tend to be transparent with their customers. Consequently, if you visit their website you will notice numerous positive reviews which is an indicator that HealthworxCBD is a trusted brand.

3. CBDistillery

Highlights

  • Full-spectrum, broad-spectrum, CBG and CBD Isolate
  • Third-party lab tested
  • 250mg to 5000mg of CBD potency
  • US Hemp Authority Certified

Another brand that found its place on our list of the best CBD oil for pain is CBDistillery. This Colorado-based brand has been on the market for a while and highly values the trust of its customers. On top of that, buying from them you get great quality at a reasonable price.

One of the reasons why CBDistillery has a high reputation is transparency. They test all their products to verify the content and purity and publish the results. The goal is to make sure all consumers know what they are buying. At CBDistillery you can buy full-spectrum or THC-free CBD oil with different strengths according to your needs or preferences.

4. Charlotte’s Web

Highlights

  • Different flavors – lemon twist, orange blossom, olive oil, mint chocolate
  • Organic hemp
  • Natural ingredients
  • 17mg CBD per 1ml serving for beginners

One of the best things that makes this CBD oil stand out from the rest is the flavor. Charlotte’s Web created CBD oils with 4 different tastes to make the CBD experience better. You can choose from a lemon twist, orange blossom, olive oil, mint chocolate, or get their original formula if you are not a fan of these flavors. Another interesting fact is that they sell a product for beginners or people who don’t like to consume strong oils. If you are trying CBD oil for the first time you should get 17mg per 1ml serving CBD oil.

Charlotte’s Web prides itself on making CBD oils rich in naturally-occurring phytocannabinoids, terpenes, flavonoids, and other natural ingredients. The hemp they use is organic and originates from Colorado. Like other reputable companies, they test their products by third-party labs and the lab results are available to download them from their website.

5. PureKana

Highlights

  • Hemp-derived CBD
  • Organic Kentucky-grown hemp
  • CO2 extraction method
  • 4 flavors – vanilla, mint, natural, citrus

Purekana has been on the market for a long time and is one of the most trusted brands in the USA. They use only organic Kentucky-grown hemp which is a standard for quality. If you choose to try their CBD oil you have the opportunity to get it in a different flavor. There is a CBD oil with natural “earthy” taste for those who like it and vanilla, mint, and citrus. All products are third-party laboratory tested for content and contain less than 0.3% THC.

Furthermore, the Purekana CBD oils have three strengths – 300, 600, and 1000 mg CBD. Overall, you can’t go wrong in choosing to try CBD oil made by Purekana.

6. Nuleaf Naturals

Highlights

  • Organic hemp oil
  • Full-spectrum hemp extract
  • Lab-tested
  • Selling only CBD oil tinctures

Nuleaf Naturals has been selling CBD oil for the past five years and even though it has got a good reputation it hasn’t extended its line of products. Even better, they are focused on providing a premium quality CBD oil drops and tinctures for all purposes. Nuleaf Naturals use only 100% natural hemp to extract CBD and like all trusted brands test the products through third-party labs.

At their store, you can find 5 types of CBD oils – all with different sizes from 5ml to 100ml. Nuleaf Naturals CBD oil is free from preservatives, additives which are usually present in low-quality oils. Here you can get highly effective full-spectrum CBD oil.

7. Royal CBD

Highlights

  • Three flavors – natural, citrus, mint
  • MCT coconut oil mixed with full-spectrum hemp extract
  • Organic ingredients
  • Strengths – 250 mg, 500 mg, 1000 mg and 2500 mg

Royal CBD stands for all organic. Not only that they use organic ingredients in the CBD oil production, but they even use sustainable materials for its packaging. They are truly committed to providing quality and make sure to test each batch to keep up the standard. Using full-spectrum hemp extract their CBD oil is proven to be effective and available in various flavors and strengths. Mixed with MCT coconut oil this product increases the bioavailability of CBD in the body.

You have the option to get naturally flavored CBD oil, citrus or mint flavor. Royal CBD is a relatively new brand, but it seems that it’s finding its place high on the list of the best CBD oil for pain.

How to Recognize a High-Quality CBD Oil?

What is the best way to determine whether a CBD oil is of high quality? With so many CBD brands on the market selling their product and promoting it as the best, it’s understandable that anyone would have doubts about choosing the right one. But, how to verify it?

There are a few factors you need to take into consideration when doing your search for CBD oil. On top of the list is the source of hemp used to extract CBD. It’s of prime importance that the CBD oil you consume to treat any ailment should be made from the organic non-GMO hemp plants. If the source of the hemp is from the American fields this is an important indication that the end-product will be top-grade.

Next, find out how the CBD is extracted. The best one is the CO2 extraction process where there are no harmful solvents included which is up to the highest standards. CO2 in the role of a solvent preserves the purity of CBD. Also, the type of CBD plays an important role in the quality of the oil. There are two main parts – the full-spectrum CBD, broad-spectrum, and CBD Isolate. The main difference between all three is the content. The isolate, as the name implies, is pure CBD, no other cannabinoids are included and the broad spectrum has multiple cannabinoids and no THC. Full-spectrum has the combination of CBD and THC which gives the so-called “entourage effect”. In other words, when these two substances are combined together they can be more effective than used alone.

Finally, any reputable CBD brand uses a third-party lab to test the quality, content, and purity of the products. These labs verify whether there are any heavy metals or pesticides and if all ingredients listed on the labels are actually included in the product in the right amount. The lab results should be published on the official website or available upon request. If a brand at any occasion refuses to provide them then something must be wrong.

Is CBD Oil Legal?

Since 2018, all products that contain CBD in its compound are considered legal. According to the Agriculture Improvement Act of 2018 also known as Farm Bill, all these products have been regulated and approved. Still, the level of THC needs to be lower than 0.3% and any CBD oil or cream containing THC over that level is considered illegal.
Colorado has been the first state that has legalized the CBD products and many states in the USA have a different provision. It’s advised that you check the state regulation before purchasing this type of product.

Benefits of CBD Oil for Pain

CBD is still the number one topic for many researchers. It seems that the benefits of using CBD oil are endless. Many users have reported all kinds of improvements in treating many ailments such as chronic pain, anxiety, sleep deprivation, stress, and even in reducing symptoms and side effects of some diseases.

When people consume CBD, this cannabinoid connects with the endocannabinoid system or abbreviated as ECS and it directly helps in keeping the balance of all internal processes in the body. It helps with the immune boost and keeps homeostasis whenever the body is attacked.

If extracted from organic hemp, CBD has plenty of therapeutic properties, and mixed with natural ingredients can only provide support and is not harmful. For that reason, CBD oil is used even by people that don’t suffer from chronic pain or diseases but are only looking for stress relief or relaxation.

What is the Recommended Dosage of CBD Oil?

The most important thing to have in mind when purchasing CBD oil is to be attentive to the potency of the product and consider the purpose of its use. There is no standard dosage for any CBD product due to the many factors that influence its effectiveness. Every manufacturer normally provides its users with a recommended dosage based on the strength of the CBD oil, but you should be the one to determine the right dosage for yourself.

Don’t worry, that is not a difficult thing to do – there are just a few things to have in mind before you choose your dose. Above all, CBD has different effects on people based on their weight and height. Logically, a higher dose would apply for users that have a higher weight, or a stronger dose. Next, it depends on the condition you are trying to treat whether you should get 1 drop per day or more. Again, consider the strength of the oil.

Finally, if you have never tried CBD before you should always start with a low dosage, regardless of your body or your condition. Give yourself some time to adjust to it and see how it works only.

Is CBD Oil Safe?

In some cases, there is a chance that you wouldn’t be able to determine the suitable dosage for you and end up getting a few drops of CBD more than recommended, have no fear. CBD oil will not cause any health issues if you overdose. All products that contain CBD are considered generally safe.

Even so, there are some mild side effects that might appear and that you should be aware of. These may be a result of your body adjusting to CBD or other factors. Some expected side effects are dry mouth, drowsiness, fatigue, or change in appetite. This might cause a change in your weight and of course a higher sense of thirst. Compared to the side effects that appear as a result of some traditional therapies, these side effects are minor and not at all serious. In any case, they shouldn’t be a cause for concern.

Bottom Line

As you probably learned, finding the right CBD oil for pain takes a lot of work and plenty of research to do. There are so many CBD brands that can trick you into buying a low-grade product if you don’t have enough knowledge on the topic. This is what motivated us to make this list of the most reputable brands that sell CBD oil and make your job easier. Hopefully, we succeeded in it. Lastly, whichever brand you decide to choose in the end, don’t forget to consult with your doctor before you try it. It doesn’t harm to get a professional opinion from the person who is examining your health condition and would probably have a piece of good advice for you.

CULTIVATED: An inside look at Eaze — Cuts at Caliva — Dismal earnings for Canopy Growth – Business Insider – Business Insider

Welcome to Cultivated, our weekly newsletter where we’re bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar global cannabis boom.

Sign up here to get it in your inbox every week.

If you want a discount to BI Prime to read our stories, sign up here!

Happy Friday everyone,

It’s been quite a busy week here as I got my feet under me, returning back to my „normal” beat. I’m proud of the work Yeji and I did — along with guidance from my editor Zach — on our deep dive into Eaze’s scaled-back ambitions from 2017 to now.

The startup’s ups and downs over the past three years provide insight into the wild ride that cannabis startups, investors, and employees have been on since US states began legalizing the drug.

The other big piece of news this week was Canopy Growth’s dismal earnings. The Constellation Brands-backed company lost $1.3 billion this quarter, as the coronavirus pandemic hurt retail sales in Canada and the US.

Analysts reacted mostly negatively to the news following the earnings call today, with some questioning the new leadership team’s ability to steer the ship. 

„More worrying for us were comments around the need to ‚understand what consumers want’. Probably the worst thing to hear from a market share leader,” Jefferies analysts wrote in a note.

That being said, Canopy Growth is still the largest cannabis company. And with a deep-pocketed alcohol giant backing the company — along with a new(ish) CEO, David Klein — it’s probably not time to count them out yet.

I’ll be speaking to Klein later this afternoon as well.

-Jeremy

Here’s what we wrote about:

An inside look at Eaze’s latest pitch deck reveals vastly scaled back ambitions from the once-soaring cannabis startup

Internal documents and interviews reveal Eaze’s vastly scaled-back ambitions. In 2017, Eaze — then a cannabis delivery service — projected that it would sell $1 billion worth of marijuana on the platform and aggressively expand to new states.

In 2020, under the guidance of a new executive team and after a round of layoffs, Eaze has pared back that expectation to $190 million in sales.

We took a deep dive into the company’s financial projections from 2017 to the present and published its full 2020 pitch deck. 

Cannabis startup Caliva laid off 20 employees including a top retail exec as headwinds from the coronavirus pandemic upend the industry

Cannabis startup Caliva laid off 20 employees from its corporate office on March 30, the company confirmed.

The cuts mostly affected employees in the retail management division and included Elizabeth Cooksey, a senior exec who was brought in to drive Caliva’s retail strategy in 2019.

  • Red Light Holland, a CSE-listed psychedelics company that is planning to produce and sell branded „magic truffles” in the Netherlands, has appointed comedian Russell Peters as its Chief Creative Officer. Former Canopy Growth CEO Bruce Linton is the company’s advisory chair. 
  • CSE-listed TerrAscend closed a $37 million private placement on Friday. The deal was upsized from $30 million, and investors include Jason Karp, the founder of Tourbillon Capital Partners and CEO of HumanCo. TerrAscend reported earnings on Thursday with $34.8 million in net sales in Q1 2020.

Lavish parties, greedy pols and panic rooms: How the ‚Apple of Pot’ collapsed (Politico)

A hidden origin story of the CBD craze (New York Times)

Get ready for pharmaceutical grade magic mushroom pills (Vice)

Cannabis binge in quarantine lifts hope for federal legalization (Bloomberg)

Justice Department blocks ‚essential’ marijuana workers from bankruptcy protection (Wall Street Journal)

Not so green on the other side: How a Russian tycoon’s $165 Million U.S. cannabis bet went up in smoke (Radio Free Europe)

Ancient people in the Kingdom of Judah may have gotten high off weed – Livescience.com

More than 2,700 years ago, worshipers at a „holy of holies” shrine in Israel may have gotten high on weed. Researchers discovered burnt cannabis and frankincense at the site, which was located in the Kingdom of Judah.

Researchers made the discovery after analyzing ancient residues left on two altars at the shrine. The burnt cannabis is „the first known evidence of [a] hallucinogenic substance found in the Kingdom of Judah,” a region that now includes parts of the West Bank and central Israel, the researchers wrote in the study.

Once the cannabis was burned at the Iron Age site, „we can assume that the religious altered state of consciousness in this shrine was an important part of the ceremonies that took place here,” study lead researcher Eran Arie, the curator of Iron Age and Persian period archaeology at the Israel Museum in Jerusalem, told Live Science in an email.

Related: Image gallery: 7 potent medicinal plants

Archaeologists first excavated the site in the 1960s; they unearthed two fortresses, dating to from the ninth to the early sixth centuries B.C., that flanked the southern border of the Kingdom of Judah. During these excavations, archaeologists found a well-preserved shrine dating to about 750 B.C. to 715 B.C. 

At the shrine’s entrance were two limestone altars, one standing 18 inches (40 centimeters) high and the other 20 inches (50 cm) tall. Each altar had a shallow depression on top containing „round heaps of black solidified organic material,” the researchers wrote in the study. Based on the altars’ characteristics, researchers concluded this was a „holy of holies” shrine, meant to evoke the inner sanctum of the Tabernacle of the Israelites, where God was thought to appear. Tests of this black gunk in the 1960s gave mostly inconclusive results, noting only that one clump contained animal fat. 

Image 1 of 8

A view of the shrine, with a bird's-eye view of the depressions and burnt remnants on top of each altar.

A view of the shrine, with a bird’s-eye views of the depressions and burnt remnants on top of each altar. (Image credit: Israel Antiquities Authority Collection, Photo © The Israel Museum, Jerusalem, by Laura Lachman)

Image gallery

Image 2 of 8

The shorter altar stands 18 inches (40 cm) high.

The shorter altar stands 18 inches (40 cm) high. (Image credit: Israel Antiquities Authority Collection, Photo © The Israel Museum, Jerusalem, by Laura Lachman)

Image 3 of 8

The top of the shorter altar had the burnt remains of cannabis and animal dung.

The top of the shorter altar had the burnt remains of cannabis and animal dung. (Image credit: Israel Antiquities Authority Collection, Photo © The Israel Museum, Jerusalem, by Laura Lachman)

Image 4 of 8

The altars stood next to one another at the shrine.

The altars stood next to one another at the shrine. (Image credit: Israel Antiquities Authority Collection, Photo © The Israel Museum, Jerusalem, by Laura Lachman)

Image 5 of 8

The taller altar stands 20 inches (50 cm) tall.

The taller altar stands 20 inches (50 cm) tall. (Image credit: Israel Antiquities Authority Collection, Photo © The Israel Museum, Jerusalem, by Laura Lachman)

Image 6 of 8

The burnt remnants of the frankincense and animal fat on the taller pillar.

The burnt remnants of frankincense and animal fat were detected on the taller pillar. (Image credit: Israel Antiquities Authority Collection, Photo © The Israel Museum, Jerusalem, by Laura Lachman)

Image 7 of 8

A drawing of the Tel Arad fortress

A drawing of the Tel Arad fortress (Image credit: © The Israel Museum, Jerusalem, by Esther Stark)

Image 8 of 8

The shrine was rebuilt at the Israel Museum.

The shrine was rebuilt at the Israel Museum. (Image credit: Israel Antiquities Authority Collection, Photo © The Israel Museum, Jerusalem, by Laura Lachman)

Arie decided to reanalyze this black material, especially since some residue still remained on the altars. He teamed up with study co-researcher Dvory Namdar, a senior research fellow at the Institute of Plant Sciences at the Volcani Center of Agricultural Research in Israel. Namdar has expertise in analyzing residue from ancient burned incense, but „we never thought we [would] reveal such an amazing find” as the cannabis, Arie said. 

However, Namdar was worried that the sample could have been contaminated; at the time, she worked in a lab that conducted cannabinoid research. So, the researchers „re-sampled the altars and verified the results in another laboratory at the Hebrew University of Jerusalem,” Arie said. „The results were the same.”

Ceremonial burning

The new tests revealed that the smaller altar contained burned cannabis and animal droppings. It appears that „animal dung was used as the fuel [to burn] the cannabis,” Arie said. Dung burns more slowly than herbs, so it would have slowed down the burning process, he said.

The taller altar contained the remnants of frankincense and animal fat, which would have promoted evaporation of the aromatic tree resin. It’s the earliest evidence that frankincense was used in a cultic practice in the Kingdom of Judah, Arie said. 

Both of these findings provide clues about cultic practices in the Kingdom of Judah. In particular, the cannabis finding indicates that people may have purposefully used the plant for its „hallucinogenic ingredients,” to stimulate ecstasy during cultic ceremonies, at least during the eighth century B.C., Arie said. 

Practices at this shrine may also shed light on the First Temple, also known as Solomon’s Temple, which was also in the Kingdom of Judah and in use at the same time. The shrine at Arad „was an official shrine of the Kingdom of Judah,” Arie said, so it’s possible that these findings can be „extra-biblical evidence” that similar practices were used in the First Temple, Arie said. 

In other words, the bible mentions that frankincense was burned in the First Temple, but because this shrine used both cannabis and frankincense, these substances „were probably also (at least) part of the components of the incense that was burnt in the Temple in Jerusalem,” Arie said.

Related: Photos: The ancient ruins of Shivta in southern Israel

Where did these burned ingredients originate? Frankincense comes from Arabia, so it’s likely that the Kingdom of Judah took part in the south Arabian trade, even before the Assyrian empire encouraged such practices starting in 701 B.C., the researchers said. Moreover, it probably wasn’t cheap. „The high value of frankincense is further reflected in the Bible, where its price is compared several times with that of gold and precious stones, and it is often described as a royal treasure,” the researchers wrote in the study.

Cannabis, in contrast, isn’t local to the Middle East. Rather, cannabis originated high on the Tibetan Plateau, according to a study of fossil pollen. What’s more, there aren’t any cannabis seeds or pollen remains known in the ancient Near East’s archaeological record. So, it’s possible that cannabis plants „may have been imported from distant origins and were transported as dried resin (commonly known as hashish),” the researchers wrote in the study. 

The new finding „is revolutionary in making a case for the use of specialized psychoactive plants in early Israelite religion,” said Patrick McGovern, the scientific director of the Biomolecular Archaeology Project at the Penn Museum in Philadelphia, who was not involved in the study.

However, McGovern said the study could have delved deeper into the cannabis findings. „The proposal that the cannabis was heated to release psychoactive compounds, rather than for its aroma as an incense (provided by the frankincense, in any case), is an intriguing proposition,” he said. 

It’s interesting that the Hebrew Bible doesn’t appear to mention cannabis use, and that there isn’t any known archaeobotanical evidence for the plant at the shrine, he noted. That said, it may not be far-fetched, given that people in the Kingdom of Judah did use another mind-altering substance in rituals, namely alcohol, McGovern said. The study doesn’t mention „the psychoactive properties of grape wine, which we know to have played a central role in early Israelite religion,” McGovern said. 

The study was published online yesterday (May 28) in the journal Tel Aviv

Originally published on Live Science.

Cannabis Industry Continues to Provide Aid to Communities in Need Amid COVID-19 Pandemic – Cannabis Science and Technology

Personal protective equipment (PPE) has been a difficult item to track down during the COVID-19 global pandemic. Extract Consultants, a provider of terpenes, flavors, and effects blends that are specifically designed for the tetrahydrocannabinol (THC) and hemp industries, recently saw the need and urgency for PPE materials in their Denver communities.

In May, Extract Consultants published a press release informing the public that they had donated 700 KN95 masks to Denver Health’s Ernest E. Moore Shock Trauma Center, which is reportedly one of the highest volume trauma centers in the nation, managing trauma cases from Colorado and six neighboring states. Extract Consultants said they were honored to donate masks to this facility in their press release (1).

“Treating COVID-19 patients while safely providing ongoing medical care for other conditions requires Denver Health to think creatively, act fast and take extraordinary measures at great but necessary expense,” said Linda Ford, Denver Health Executive Director (2). “Extract Consultants’ generous contribution of face masks makes that a reality.”

Their thoughtful gesture did not end with PPE donations. With the COVID-19 pandemic, many are out of work and unable to provide for their families. Extract Consultants provided a financial contribution to the Food Bank of the Rockies, which will contribute to approximately 12,000 meals to its Denver communities facing food insecurities (2). The Food Bank of the Rockies is the largest private hunger-relief organization in Colorado and Wyoming.

“This crisis has brought to bear the ever-present need for goodwill and generosity in our local community,” said Extract Consultants President Maxwell Brown (2). “We’re grateful to be able to support these vital organizations serving the most vulnerable here in Denver.”

From Extract Consultant’s press release, the company commented further on the amount of donations and other assistances being performed by other cannabis establishments (1): “We continue to be awed by the incredible acts of compassion and generosity shown by those within and without our industry. We are all truly in this together.” Businesses in the cannabis industry continue to pursue ways on how to aid each other and their communities to get through these difficult times (3,4).